Head and Neck Cancer Treatment Market - Global Forecasts and Opportunity Assessment by Technavio

Technavio has published a new report on the global head and neck cancer treatment market from 2017-2021. (Graphic: Business Wire)

LONDON--()--According to the latest market study released by Technavio, the global head and neck cancer treatment market is expected to target a CAGR of more than 8% during the forecast period.

This research report titled ‘Global Head and Neck Cancer Treatment Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

The major factors driving the global head and neck cancer treatment market growth are growing cases of the lip and oral cavity cancer especially in the developing countries such as India, Pakistan, and China and rising funding for R&D in the oncology sector. Also, it has been seen that rising age can also be an additional risk leading to a high prevalence rate of head neck cancer.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio’s analysts categorize the global head and neck cancer treatment market into four major segments by cancer type. They are:

  • Oral cavity cancer
  • Laryngeal cancer
  • Pharyngeal cancer
  • Others

The top three segments based on cancer type for the global head and neck cancer treatment market are discussed below:

Oral cavity cancer

Oral cavity cancer appears as a sore in the mouth that does not go away. This cancer is commonly seen in the tongue, lips, floor of the mouth, cheeks, and hard palate. This form of cancer can be life-threatening, in case of delay in diagnosis and treatment of the disease.

According to Sapna Jha, a lead oncology research analyst from Technavio, “Oral cavity cancer is the most common type of the head and neck cancer. The segment held over 47% share of the total head and neck cancer in 2016. Also, it is expected to be the fastest growing segment during the forecast period majorly due to high consumption of tobacco and alcohol and betel nut chewing across the globe.”

Laryngeal Cancer

Laryngeal cancer is a type of head and neck cancer that develops in the tissues of the larynx. The Tumor, Node, and Metastasis (TNM) staging is a common way of describing the stage of cancer. In laryngeal cancer, the tumor stage defines how far has the cancerous cells grown in the larynx and the surrounding tissues. Node stage defines the spread of cancer in the lymph nodes.

South Asian countries such as India and Sri Lanka are expected to witness higher demand of the laryngeal drugs. On the other side, China is expected to see a rising prevalence rate of laryngeal cancer due to a high level of HPV infection,” says Sapna.

Pharyngeal Cancer

Pharyngeal cancer occurs in the pharynx. Similar to other head and neck cancers, this risk of this cancer also rises with the alcohol and tobacco consumption. Chronic viral infections are also associated with the pharynx cancer development. For instance, EBV has been strongly associated with nasopharyngeal cancer.

Occupational exposures to cancer-causing agents such as formaldehyde, which is usually found in the textile and plastic cancer, have also been found to be a risk for pharyngeal cancer. Pharyngeal cancer is further divided into three types, based on the location of the pharynx, in which the tumor has formed.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • Bristol-Myers Squibb
  • Eli Lilly
  • Merck
  • Pfizer

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like medical imaging, cardiovascular devices, and vaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Global head and neck cancer treatment market is expected to target a CAGR of more than 8% during the forecast period.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770